Knowledge Hub

Pharmaceutical Industry Research : Partnerships, Licensing, Investments and M&A Deals and Trends for November 2016

Press Release   •   Feb 02, 2017 05:05 EST

GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for November 2016 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in November 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

View Report @ http://www.marketresearchreports.biz/analysis/943726

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.

- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.

- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.

- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.

- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.

- Analysis of partnership and licensing deals based on clinical stage of development of products.

- Summary of the pharmaceutical deals globally in the six months.

- Information on the top deals happened in the pharmaceutical industry.

- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.

- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Get Sample Copy Of This Report @

http://www.marketresearchreports.biz/sample/sample/943726

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.

- Find out the major deal performing segments for investments in your industry.

- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.

- Identify companies that are aggressively looking to raise capital in the market

- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.

- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.

- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.

- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.

- Identify growth segments and opportunities in each region within the industry.

- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 9

2 Pharmaceuticals & Healthcare, Global, Deal Summary 12

2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, November 2016 12

2.2 Pharmaceuticals & Healthcare, Global, Major Deals, November 2016 14

2.2.1 Abbott Labs Prices Public Offering of Notes for USD15.1 Billion 14

2.2.2 Pfizer Raises USD6 Billion in Public Offering of Notes 14

2.2.3 Bayer Raises USD4.3 Billion in Private Placement of Convertible Notes due 2019 15

2.2.4 Allergan Acquires Chase Pharma 15

2.2.5 Mitsubishi Tanabe Pharma Enters into Licensing Agreement with Kolon Life Science 16

2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, November 2016 17

2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, November 2016 18

3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 19

3.1 Pharmaceuticals & Healthcare, Global, M&A, November 2016 19

3.1.1 Top M&A Deals in November 2016 20

3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, June 2016 - November 2016 21

3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, November 2016 22

3.2.1 Top Equity Offering Deals in November 2016 23

3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, June 2016 - November 2016 24

3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, November 2016 25

3.3.1 Top PE/VC Deals in November 2016 26

3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, November 2016 27

3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, November 2016 28

3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, June 2016-November 2016 29

3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, June 2016-November 2016 30

3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, November 2016 31

3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, June 2016 - November 2016 33

3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), November 2016 34

3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, November 2016 35

3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), June 2016 - November 2016 36

3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, June 2016 - November 2016 38

3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), June 2016 - November 2016 39

3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), June 2016 - November 2016 41

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.